Dow Down 0.18% Nasdaq Down 0.33%

NeurogesX, Inc. (NGSX)

-Other OTC
0.00 0.00(5.13%) Oct 29, 9:42AM EDT
Prev Close:0.00
Open:0.00
Bid:N/A
Ask:N/A
1y Target Est:1.00
Beta:1.52
Next Earnings Date:N/A
Day's Range:0.00 - 0.00
52wk Range:0.00 - 0.41
Volume:29,273
Avg Vol (3m):81,109
Market Cap:123.63K
P/E (ttm):N/A
EPS (ttm):-0.96
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for NGSX at this time.

Comparison

Symbol% ChgMkt Cap
NGSXDown 5.13%123.63K
LLY70.36B
ENDP10.08B
PFE186.99B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):0.01
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (0-00-31) :N/A
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

NeurogesX, Inc., a biopharmaceutical company, engages in developing and commercializing pain management therapies. The company offers Qutenza for the management of neuropathic pain associated with postherpetic neuralgia, and for the treatment of p... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback